EAM
GWPH

EverPoint Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

EverPoint Asset Management’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2.23M Buy
+20,000
New +$2.41M 0.04% 317

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

EverPoint Asset Management's GWPH Position: Q4 2016 in Review

EverPoint Asset Management opened a new position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2016: 20,000 shares worth $2.23M. The stake represents 0.04% of the portfolio and ranks #317 among its holdings.

164 funds tracked by Wall St. Rank hold GWPH as of Q4 2016.

  • EverPoint Asset Management held 20,000 shares of GW Pharmaceuticals Plc American Depositary Shares worth $2.23M as of Q4 2016.
  • GW Pharmaceuticals Plc American Depositary Shares was a new EverPoint Asset Management position in Q4 2016.
  • GW Pharmaceuticals Plc American Depositary Shares made up 0.04% of EverPoint Asset Management's portfolio in Q4 2016, its #317 holding.
  • 164 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.